$8M Pharmacy NNN Acquisition Phoenix | Commercial Lending Solutions 
Loan Size Example

$8 Million Pharmacy NNN Acquisition in Phoenix

By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions

An $8 million pharmacy NNN acquisition in Phoenix represents a core-plus single-tenant net lease play in a market where drugstore density and demographic tailwinds support long-term tenant viability. Phoenix's sprawling suburban footprint and growing population make pharmacy real estate a reliable investment for net lease buyers seeking stable cash flow and minimal operational burden. Most lenders in this space are national banks with dedicated STNL programs, life insurance companies seeking longer-term holds, and CMBS conduits targeting lease-backed cash flows. Typical leverage runs 65 to 72 percent LTV depending on tenant credit rating and remaining lease term, with rates in the 6.0 to 6.5 percent range for investment-grade tenants.

Get a Quote on Your $8M Deal →
Capital Stack

What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like

A national bank STNL program typically leads the $8 million pharmacy financing in Phoenix, offering CMT-based pricing, 10 to 15 year fixed terms, and non-recourse optionality at 60 to 65 percent LTV. Life insurance companies and dedicated STNL debt funds round out the landscape as secondary or alternative sources when bank capacity is constrained or when sponsors prefer longer amortization or stronger recourse relief.

Capital Source Rate / Cost Size / LTV Notes
National bank STNL program 6.25 percent fixed (CMT-based 10-year); 25 to 30 year amortization $5.6M to $6.0M (70 to 75 percent LTV) Most common source; investment-grade tenant credit required (A-/BBB+ and above); non-recourse available at 60 to 65 percent LTV; tight underwriting on lease remaining term (minimum 8 to 10 years typical)
Life insurance company direct lender 6.4 to 6.75 percent fixed; 30 to 35 year amortization $4.8M to $6.0M (60 to 75 percent LTV) Slower closing timeline (60 to 90 days); preference for net leases with 10+ years remaining; portfolio lender mindset; recourse negotiable; competitive on longer-term holds
Regional CMBS conduit (STNL program) 6.5 to 6.75 percent; fixed or floating; 25 to 30 year amortization $5.2M to $6.8M (65 to 85 percent LTV) Higher leverage available but tighter covenant package; loan-level pricing varies by trustee appetite for pharmacy asset class; typically full recourse; closing in 60 to 75 days
Credit union or smaller regional bank STNL program 6.5 to 7.0 percent; fixed 10 to 15 years $3.2M to $5.6M (40 to 70 percent LTV) Subordinate or gap-funding role; faster decisions for strong sponsors with local relationships; recourse common; useful when primary bank loan caps at $6M and sponsor wants full amortization

Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.

Sponsor Profile

Who Closes a $8M Pharmacy NNN Acquisition Deal

Typical sponsors are net lease-focused investors with $5M to $25M net worth, 10+ acquired properties, and experience in 1031 exchanges or portfolio diversification strategies. Many are private investors, small family offices, or REITs seeking Phoenix's growth demographic and relative valuation discount versus coastal markets. Motivations include redeploying capital from 1031 exchanges, acquiring a trophy pharmacy asset with A-grade tenant credit, or building a small portfolio of inflation-protected NNN leases.

From the CLS CRE Pipeline

A Real $8M Example

CLS CRE closed an $7.8 million pharmacy NNN acquisition in a north Phoenix submarket on behalf of a 1031 exchange buyer seeking long-term hold cash flow. The property was a single-tenant, ground-leased modern pharmacy building with an investment-grade national tenant and 14 years remaining on the triple-net lease. We secured financing from a national bank STNL program at 6.2 percent fixed, 72 percent LTV, 30-year amortization, with non-recourse carve-outs limited to fraud and environmental. The sponsor closed in 48 days and deployed the balance from his prior commercial property sale, achieving a 4.1 percent cash-on-cash return in year one.

Anonymized. All deal references protect borrower and lender identity.

FAQ

$8M Pharmacy NNN Acquisition Phoenix FAQ

Most national banks and life companies require investment-grade tenant credit (A- to A rating or equivalent) for full leverage. BBB+ tenants are acceptable at slightly reduced LTV (65 to 70 percent) and higher rates. Any tenant below investment grade typically requires sponsor equity step-up and lower advance rate.
Lease term is a critical gating factor; lenders typically require minimum 8 to 10 years remaining (some prefer 12+). Each year below that threshold reduces advance rate by 1 to 2 percent and adds 15 to 25 basis points to the rate. A 14+ year lease qualifies for best pricing and highest leverage; a 7 to 8 year lease may require 60 to 65 percent LTV and 6.75 to 7.0 percent pricing.
Yes, non-recourse is available at 60 to 65 percent LTV from national bank STNL programs and life insurance companies. Carve-outs for fraud, environmental liability, and lease default are standard. Full recourse terms at 70 to 75 percent LTV typically cost 20 to 40 basis points less and appeal to sponsors comfortable with personal guarantee.
National bank STNL programs close in 45 to 60 days; life insurance companies take 60 to 90 days due to portfolio underwriting depth. CMBS conduits average 60 to 75 days. Appraisal, title, lease review, and tenant verification are the main variables; pharmacy assets typically move faster than multi-tenant properties.
Yes, 1031 exchange sponsors represent 40 to 50 percent of net lease acquisition buyers in Phoenix. Pharmacies appeal to this pool because of strong demographics, long-term tenant relationships, and predictable cash flows that fit qualified intermediary timelines and due-diligence windows.


Get a Quote on Your $8M Deal

Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.

Apply for Financing →
Or call us: 310.708.0690

Weekly Market Intelligence

Rate updates, deal insights, and capital markets analysis. One email per week. Unsubscribe anytime.

No spam. No selling your data. Just market intelligence from a working broker.

Need financing? Apply in 2 minutes. Response within 24 hours.
Apply Now →
📈

Before You Go…

Get matched with the right lender from our network of 1,000+ capital sources.

Or call us: 310.708.0690

No spam. Unsubscribe anytime.